Patients | Sex | Age (years) | TSHa (mU/l) | FT4b (pmol/l) | TPOAbsc (IU/ml) | TgAbsd (IU/ml) | TRABse (IU/l) |
---|---|---|---|---|---|---|---|
1 | F | HT 3.0 | 7.10 | 12.6 | 95 | 60 | <1.0 |
GD 5.5 | 0.0500 | 45.1 | 796 | 150 | 23.4 | ||
2 | F | HT 3.0 | 19.56 | 9.9 | 1310 | 182 | <1.0 |
GD 9.0 | 0.0500 | 36.8 | 1300 | 79 | 19.0 | ||
3 | F | HT 3.3 | 0.07 | 24.6 | 57 | 187 | <1.0 |
GD 4.0 | 0.0060 | 47.8 | 44 | 148 | 85.0 | ||
4 | M | HT 4.0 | 8.80 | 16.8 | 180 | 120 | <1.0 |
GD 9.9 | 0.0500 | 66.1 | 278 | 199 | 32.7 | ||
5 | F | HT 4.0 | 5.30 | 12.1 | 26 | 28 | <1.0 |
GD 8.8 | 0.0001 | 41.9 | 149 | 758 | 25.2 | ||
6 | M | HT 5.0 | 0.05 | 50.0 | 284 | 35 | <1.0 |
GD 6.1 | 0.0500 | 41.6 | 189 | 170 | 22.0 | ||
7 | F | HT 5.9 | 5.10 | 17.4 | 75 | 302 | <1.0 |
GD 11.1 | 0.0100 | 31.6 | 248 | 55 | 28.0 | ||
8 | F | HT 6.0 | 8.20 | 10.5 | 144 | 104 | <1.0 |
GD 9.0 | 0.0500 | 26.0 | 39 | 3 | 21.0 | ||
9 | M | HT 8.0 | 0.01 | 38.0 | 278 | 199 | <1.0 |
GD 10.0 | 0.0050 | 58.7 | 278 | 199 | 32.7 | ||
10 | M | HT 9.7 | 9.10 | 11.0 | 37 | 2 | <1.0 |
GD 13.2 | 0.0200 | 29.4 | 200 | 200 | 23.0 | ||
11 | M | HT 10.0 | 8.10 | 10.5 | 22 | 119 | <1.0 |
GD 15.0 | 0.0010 | 34.4 | 45 | 220 | 16.0 | ||
12 | F | HT 13.5 | 4.30 | 18.0 | 23 | 109 | 1.0 |
GD 20.0 | 0.0060 | 25.0 | 61 | 117 | 31.4 |